Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7080839rdf:typepubmed:Citationlld:pubmed
pubmed-article:7080839lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7080839lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:7080839lifeskim:mentionsumls-concept:C0024297lld:lifeskim
pubmed-article:7080839lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:7080839lifeskim:mentionsumls-concept:C0086168lld:lifeskim
pubmed-article:7080839lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:7080839lifeskim:mentionsumls-concept:C1516240lld:lifeskim
pubmed-article:7080839pubmed:issue2lld:pubmed
pubmed-article:7080839pubmed:dateCreated1982-7-8lld:pubmed
pubmed-article:7080839pubmed:abstractTextActivation of monocytes with lymphokines from BCG-stimulated lymphocytes increased the capacity to inhibit DNA-synthesis in a tumour cell line (NHIK 3025) at all stages of monocyte maturation in vitro. However, the capacity of monocytes to suppress DNA-synthesis in mixed lymphocyte cultures (MLC) was reduced, indicating a dissociation of the immuno-suppressive and tumour cell cytostatic functions of lymphokine-activated monocytes. Supernatants of lymphokine-activated monocytes inhibited DNA synthesis in the tumour cell line, but not in MLC. Monocytes from donors with a strong tuberculin reaction produced supernatants with a stronger cytostatic activity than monocytes from donors with a weak tuberculin reaction. By in vitro maturation, even the later monocytes acquired ability to produce supernatants that were strongly inhibitory to tumour cells.lld:pubmed
pubmed-article:7080839pubmed:languageenglld:pubmed
pubmed-article:7080839pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7080839pubmed:citationSubsetIMlld:pubmed
pubmed-article:7080839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7080839pubmed:statusMEDLINElld:pubmed
pubmed-article:7080839pubmed:monthAprlld:pubmed
pubmed-article:7080839pubmed:issn0108-0202lld:pubmed
pubmed-article:7080839pubmed:authorpubmed-author:UnsgaardGGlld:pubmed
pubmed-article:7080839pubmed:authorpubmed-author:LamvikJJlld:pubmed
pubmed-article:7080839pubmed:authorpubmed-author:HammerstrømJJlld:pubmed
pubmed-article:7080839pubmed:issnTypePrintlld:pubmed
pubmed-article:7080839pubmed:volume90lld:pubmed
pubmed-article:7080839pubmed:ownerNLMlld:pubmed
pubmed-article:7080839pubmed:authorsCompleteYlld:pubmed
pubmed-article:7080839pubmed:pagination73-9lld:pubmed
pubmed-article:7080839pubmed:dateRevised2009-6-4lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:meshHeadingpubmed-meshheading:7080839-...lld:pubmed
pubmed-article:7080839pubmed:year1982lld:pubmed
pubmed-article:7080839pubmed:articleTitleDissociation between tumour cell cytostatic and immuno-suppressive capacity of human monocytes activated with lymphokines.lld:pubmed
pubmed-article:7080839pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7080839pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed